NAMPT and hepatocellular carcinoma: In hepatocellular carcinoma cells, pharmacological NAMPT inhibition resulted in changes in EMT marker proteins indicating a reversal of EMT, as well as a reduction in cellular capacity for invasion and metastasis formation, through a decrease in SIRT1 (84).